Novacap
Industry
- Pharmaceuticals
- OTC, Consumer
- Diversified
See more in Biomedtracker
Latest on Novacap
In Vivo
• By Maureen Riordan and Amanda Micklus
Financings Biopharma firms raised a total of $4.8 billion in financing in the second quarter of 2016, a 16% decrease in value from Q1's $5.8 billion. Follow-on public offerings and early-stage venture
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Cooper Cos. Inc. CooperSurgical Inc. Genesis Genetics Cooper Cos. Inc. 's women's health division CooperSurgical Inc. acquired private genetic testin